Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Smith & Nephew (SNN) Total Current Liabilities (2009 - 2025)

Smith & Nephew (SNN) posted Total Current Liabilities of $1.6 billion for Q4 2025, up 4.18% on a QoQ basis from $1.5 billion in Q4 2024, and up 4.18% year-over-year from $1.5 billion in Q4 2024.

Smith & Nephew (SNN) has 10 years of Total Current Liabilities data on file, last reported at $1.6 billion in Q4 2025.

  • In Q4 2025, Total Current Liabilities rose 4.18% year-over-year to $1.6 billion; the TTM figure through Dec 2025 stood at $1.6 billion (up 4.18% YoY), while the FY2025 annual figure was $1.6 billion, up 4.18% from the prior year.
  • Total Current Liabilities grew to $1.6 billion in Q4 2025, from $1.5 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.3 billion in Q4 2023 and bottomed at $1.5 billion in Q4 2024.
  • A 5-year average of $1.8 billion and a median of $1.7 billion in 2022 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Current Liabilities surged 32.42% — and 2024, when it slumped 32.58%.
  • Year by year, Total Current Liabilities stood at $2.1 billion in 2021, then dropped by 19.52% to $1.7 billion in 2022, then surged by 32.42% to $2.3 billion in 2023, then tumbled by 32.58% to $1.5 billion in 2024, then increased by 4.18% to $1.6 billion in 2025.
  • The last three Total Current Liabilities figures came in at $1.6 billion (Q4 2025), $1.5 billion (Q4 2024), and $2.3 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 18.38 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.32 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.50 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 4.57 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.41 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.22 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.53 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.15 Bn
10 Smith & Nephew 5.16 Bn 4.58 Bn - 1.60 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.60 Bn
Dec 31, 2024 1.53 Bn
Dec 31, 2023 2.27 Bn
Dec 31, 2022 1.72 Bn
Dec 31, 2021 2.13 Bn
Dec 31, 2020 1.69 Bn
Dec 31, 2019 1.56 Bn
Dec 31, 2018 1.47 Bn
Dec 31, 2017 1.35 Bn
Dec 31, 2016 1.35 Bn
Dec 31, 2015 1.34 Bn
Jun 30, 2015 1.23 Bn
Dec 31, 2014 1.16 Bn
Jun 28, 2014 1.15 Bn
Mar 31, 2014 1.06 Bn
Dec 31, 2013 1.07 Bn
Sep 28, 2013 3.40 Bn
Mar 31, 2013 916.00 Mn
Dec 31, 2012 930.00 Mn
Sep 29, 2012 908.00 Mn
Mar 31, 2012 1.01 Bn
Dec 31, 2011 1.12 Bn
Dec 31, 2010 914.00 Mn
Dec 31, 2009 863.00 Mn